Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
severe CDI
Description:
A serious form of Clostridioides difficile infection, a bacterial intestinal disease that can cause severe inflammation and other complications.
Primary topic:
Clostridium difficile and Clostridium perfringens research (99%)
Related topic:
Clostridium difficile and Clostridium perfringens research (99%)
OpenAlex ID:
keywords/severe-cdi
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence
2018
·
Dale N Gerding
, Ciaran P Kelly
, et al.
·
Clinical Infectious Diseases
·
224
PDF
The Long-term Efficacy and Safety of Fecal Microbiota Transplant for Recurrent, Severe, and Complicated Clostridium difficile Infection in 146 Elderly Individuals
2015
·
Manasi Agrawal
, Olga C. Aroniadis
, et al.
·
Journal of Clinical Gastroenterology
·
199
Long-term Follow-up Study of Fecal Microbiota Transplantation for Severe and/or Complicated Clostridium difficile Infection: A Multicenter Experience
2015
·
Olga C. Aroniadis
, Lawrence J. Brandt
, et al.
·
Journal of Clinical Gastroenterology
·
109
Prevalence of Clostridium difficile Infection among Solid Organ Transplant Recipients: A Meta-Analysis of Published Studies
2015
·
Suresh Paudel
, Ioannis M. Zacharioudakis
, et al.
·
PLoS ONE
·
109
PDF
Cost-effectiveness analysis of fidaxomicin versus vancomycin in Clostridium difficile infection
2014
·
D. Nathwani
, O. A. Cornely
, et al.
·
Journal of Antimicrobial Chemotherapy
·
92
PDF
Intestinal Microbiota Transplantation, a Simple and Effective Treatment for Severe and Refractory Clostridium Difficile Infection
2014
·
Hadeel Zainah
, Mona Hassan
, et al.
·
Digestive Diseases and Sciences
·
87
Vancomycin for the Treatment ofClostridium difficileInfection: For Whom Is This Expensive Bullet Really Magic?
2008
·
Jacques Pepin
·
Clinical Infectious Diseases
·
76
Cost-effectiveness of Bezlotoxumab Compared With Placebo for the Prevention of Recurrent Clostridium difficile Infection
2017
·
Vimalanand S Prabhu
, Erik R Dubberke
, et al.
·
Clinical Infectious Diseases
·
73
PDF
Gastric Acid Suppression and Outcomes in Clostridium difficile Infection: A Population-Based Study
2012
·
Sahil Khanna
, Scott L. Aronson
, et al.
·
Mayo Clinic Proceedings
·
73
PDF
Tigecycline for the Treatment of Severe Clostridium difficile Infection
2011
·
Kelly C Larson
, Paul P Belliveau
, et al.
·
Annals of Pharmacotherapy
·
73
Epidemiology of Clostridium difficile infection in two tertiary-care hospitals in Perth, Western Australia: a cross-sectional study
2014
·
N.F. Foster
, D.A. Collins
, et al.
·
New Microbes and New Infections
·
69
PDF
Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection
2015
·
Marco Falcone
, Alessandro Russo
, et al.
·
Antimicrobial Agents and Chemotherapy
·
59
Burden of Clostridium difficile Infection in Long-Term Care Facilities in Monroe County, New York
2012
·
Deepa Pawar
, Rebecca Tsay
, et al.
·
Infection Control and Hospital Epidemiology
·
57
Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile Infection: Systematic Review and Meta-analysis
2021
·
Yi Nong Song
, David Yi Yang
, et al.
·
Journal of the Canadian Association of Gastroenterology
·
46
PDF
Clinical Predictors and Risk Factors for Relapsing Clostridium difficile Infection
2010
·
Jose Cadena
, George R. Thompson
, et al.
·
The American Journal of the Medical Sciences
·
46
Epidemiology of Clostridioides difficile infections, France, 2010 to 2017
2019
·
Mélanie Colomb-Cotinat
, Laetitia Assouvie
, et al.
·
Eurosurveillance
·
42
PDF
Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland
2019
·
Jarmo Oksi
, A. Aalto
, et al.
·
European Journal of Clinical Microbiology & Infectious Diseases
·
42
PDF
Clinical Characteristics and Treatment Outcomes of Clostridium difficile Infections by PCR Ribotype 017 and 018 Strains
2016
·
Jieun Kim
, Yeonjae Kim
, et al.
·
PLoS ONE
·
42
PDF
Treatment of Recurrent and Severe Clostridium Difficile Infection
2015
·
J.J. Keller
, E.J. Kuijper
·
Annual Review of Medicine
·
41
A Hospital-based Study of the Clinical Characteristics of Clostridium difficile Infection in Children
2014
·
Jonathan D. Crews
, Hoonmo L. Koo
, et al.
·
The Pediatric Infectious Disease Journal
·
41
Risk factors and impact of Clostridium difficile recurrence on haematology patients
2017
·
Gianni B. Scappaticci
, Anthony J. Perissinotti
, et al.
·
Journal of Antimicrobial Chemotherapy
·
40
Clostridium difficile infection health disparities by race among hospitalized adults in the United States, 2001 to 2010
2016
·
Jacqueline R. Argamany
, Andrew Delgado
, et al.
·
BMC Infectious Diseases
·
40
PDF
Clinical and Economic Consequences of Vancomycin and Fidaxomicin for the Treatment of Clostridium difficile Infection in Canada
2014
·
Monika Wagner
, Louis Lavoie
, et al.
·
Canadian Journal of Infectious Diseases and Medical Microbiology
·
38
PDF
Fidaxomicin versus oral vancomycin for severe Clostridium difficile infection: a retrospective cohort study
2018
·
C.A. Gentry
, P.K. Nguyen
, et al.
·
Clinical Microbiology and Infection
·
36
Current challenges in the treatment of severe Clostridium difficile infection: early treatment potential of fecal microbiota transplantation
2017
·
Yvette H. van Beurden
, Max Nieuwdorp
, et al.
·
Therapeutic Advances in Gastroenterology
·
36
PDF
Show more works
View as search
Works count:
131
Citation count:
2,518
Year
Topic
Type